tirzepatide netherlands Mounjaro will be available in August Mounjaro (Tirzepatide): Raising the Bar

Dyslipidemia can cause symptomatic ischemic heart disease in some patients and is associated with MetS

If Youre Asking This Question, Youre Not Alone Over the past two years, one question has come up in nearly every employee benefits renewal meeting: Should our health plan cover GLP-1 medications? Medications such as Wegovy, Zepbound, Ozempic, and Mounjaro have transformed the treatment of obesity and diabetes

Attributing the result to the shot is a reasoning error, not a finding

Increased intracellular NAD was reported in selected cultured-cell experiments

Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors

Certain situations make it a reasonable, and sometimes preferable, option